Cognitive abnormality in schizophrenia: a dual-process model.
D000293:Adolescent; D000328:Adult; D001143:Arousal / Q000187:drug effects; D001288:Attention / Q000187:drug effects; D002746:Chlorpromazine / Q000627:therapeutic use; D003072:Cognition Disorders / Q000188:drug therapy / Q000523:psychology*; D003118:Color Perception / Q000187:drug effects; D003210:Concept Formation / Q000187:drug effects; D004351:Drug Resistance; D005260:Female; D005556:Form Perception / Q000187:drug effects; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D008960:Models, Psychological; D011581:Psychological Tests; D012559:Schizophrenia / Q000188:drug therapy; D012560:Schizophrenia, Catatonic / Q000523:psychology; D012562:Schizophrenia, Disorganized / Q000523:psychology; D012563:Schizophrenia, Paranoid / Q000523:psychology; D012565:Schizophrenic Psychology
D006220:Haloperidol; D002746:Chlorpromazine